Squarepoint’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $146M | Buy |
1,683,504
+1,103,876
| +190% | +$106M | 0.17% | 91 |
|
|
2025
Q4 | $55.7M | Buy |
579,628
+252,900
| +77% | +$24.6M | 0.06% | 374 |
|
|
2025
Q3 | $31.1M | Sell |
326,728
-55,525
| -15% | -$5.1M | 0.03% | 558 |
|
|
2025
Q2 | $33.3M | Buy |
382,253
+70,555
| +23% | +$5.98M | 0.03% | 532 |
|
|
2025
Q1 | $28M | Sell |
311,698
-579,971
| -65% | -$51.9M | 0.03% | 545 |
|
|
2024
Q4 | $71.2M | Buy |
891,669
+700,727
| +367% | +$60.7M | 0.07% | 276 |
|
|
2024
Q3 | $17.2M | Sell |
190,942
-495,261
| -72% | -$41.7M | 0.03% | 665 |
|
|
2024
Q2 | $54M | Buy |
686,203
+362,997
| +112% | +$29.8M | 0.09% | 215 |
|
|
2024
Q1 | $28.2M | Buy |
323,206
+37,179
| +13% | +$3.17M | 0.05% | 464 |
|
|
2023
Q4 | $23.6M | Sell |
286,027
-332,433
| -54% | -$25.3M | 0.04% | 493 |
|
|
2023
Q3 | $48.5M | Sell |
618,460
-115,610
| -16% | -$9.68M | 0.12% | 177 |
|
|
2023
Q2 | $64.7M | Buy |
734,070
+640,063
| +681% | +$55.1M | 0.2% | 96 |
|
|
2023
Q1 | $7.58M | Sell |
94,007
-451,551
| -83% | -$36.8M | 0.03% | 674 |
|
|
2022
Q4 | $42.4M | Buy |
545,558
+35,016
| +7% | +$2.84M | 0.17% | 113 |
|
|
2022
Q3 | $41.2M | Buy |
510,542
+179,062
| +54% | +$16.1M | 0.21% | 86 |
|
|
2022
Q2 | $29.8M | Buy |
331,480
+174,523
| +111% | +$17.7M | 0.17% | 131 |
|
|
2022
Q1 | $17.4M | Sell |
156,957
-848,058
| -84% | -$89.6M | 0.07% | 279 |
|
|
2021
Q4 | $104M | Buy |
1,005,015
+857,644
| +582% | +$99.3M | 0.27% | 55 |
|
|
2021
Q3 | $18.5M | Buy |
147,371
+40,697
| +38% | +$5.27M | 0.05% | 322 |
|
|
2021
Q2 | $13.2M | Sell |
106,674
-184,802
| -63% | -$23.2M | 0.05% | 365 |
|
|
2021
Q1 | $34.4M | Buy |
291,476
+132,783
| +84% | +$15.6M | 0.2% | 95 |
|
|
2020
Q4 | $18.6M | Buy |
158,693
+85,556
| +117% | +$9.42M | 0.14% | 134 |
|
|
2020
Q3 | $7.6M | Sell |
73,137
-120,020
| -62% | -$12.1M | 0.1% | 239 |
|
|
2020
Q2 | $17.7M | Buy |
193,157
+74,048
| +62% | +$7.1M | 0.29% | 67 |
|
|
2020
Q1 | $10.7M | Sell |
119,109
-72,231
| -38% | -$7.68M | 0.27% | 76 |
|
|
2019
Q4 | $21.7M | Buy |
+191,340
| New | +$21M | 0.13% | 127 |
|
|
2019
Q3 | – | Sell |
-249,389
| Closed | -$24.3M | – | 2548 |
|
|
2019
Q2 | $24.3M | Sell |
249,389
-333,894
| -57% | -$30.5M | 0.24% | 98 |
|
|
2019
Q1 | $53.1M | Buy |
583,283
+485,346
| +496% | +$43.4M | 0.56% | 25 |
|
|
2018
Q4 | $8.91M | Sell |
97,937
-316,364
| -76% | -$29.6M | 0.1% | 247 |
|
|
2018
Q3 | $40.8M | Buy |
414,301
+210,072
| +103% | +$19.4M | 0.49% | 27 |
|
|
2018
Q2 | $17.5M | Buy |
+204,229
| New | +$17.1M | 0.23% | 102 |
|
|
2018
Q1 | – | Sell |
-384,823
| Closed | -$31.1M | – | 1950 |
|
|
2017
Q4 | $31.1M | Sell |
384,823
-113,242
| -23% | -$9.07M | 0.54% | 23 |
|
|
2017
Q3 | $38.7M | Buy |
498,065
+489,979
| +6,060% | +$40.7M | 0.75% | 14 |
|
|
2017
Q2 | $718K | Sell |
8,086
-263,548
| -97% | -$22.2M | 0.01% | 822 |
|
|
2017
Q1 | $21.9M | Sell |
271,634
-50,766
| -16% | -$3.97M | 0.6% | 18 |
|
|
2016
Q4 | $23M | Buy |
+322,400
| New | +$25.3M | 0.94% | 4 |
|
|
2016
Q3 | – | Sell |
-18,406
| Closed | -$1.6M | – | 1158 |
|
|
2016
Q2 | $1.6M | Sell |
18,406
-69,213
| -79% | -$5.6M | 0.1% | 239 |
|
|
2016
Q1 | $6.57M | Buy |
87,619
+65,416
| +295% | +$4.93M | 0.51% | 22 |
|
|
2015
Q4 | $1.71M | Buy |
+22,203
| New | +$1.67M | 0.19% | 118 |
|
|
2015
Q3 | – | Sell |
-33,933
| Closed | -$2.51M | – | 515 |
|
|
2015
Q2 | $2.51M | Buy |
33,933
+22,421
| +195% | +$1.71M | 0.82% | 14 |
|
|
2015
Q1 | $898K | Buy |
+11,512
| New | +$873K | 0.31% | 102 |
|
Other funds holding MDT
VCM
VPM
Squarepoint's MDT Position: Q1 2026 in Review
Squarepoint increased its Medtronic (MDT) stake by 190% in Q1 2026, buying an estimated $106M and bringing the position to 1,683,504 shares worth $146M. The position accounts for 0.17% of the portfolio, ranked #91.
Squarepoint first reported a position in MDT in Q1 2015 and has held it in 41 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Squarepoint held 1,683,504 shares of Medtronic worth $146M as of Q1 2026.
- Squarepoint bought 1,103,876 Medtronic shares in Q1 2026, an estimated $106M.
- Medtronic made up 0.17% of Squarepoint's portfolio in Q1 2026, its #91 holding.
- Squarepoint first reported a position in Medtronic in Q1 2015 and has held it in 41 quarters since.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.